These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 22395983)

  • 1. The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study.
    Hompes D; D'Hoore A; Van Cutsem E; Fieuws S; Ceelen W; Peeters M; Van der Speeten K; Bertrand C; Legendre H; Kerger J
    Ann Surg Oncol; 2012 Jul; 19(7):2186-94. PubMed ID: 22395983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
    Verwaal VJ; Bruin S; Boot H; van Slooten G; van Tinteren H
    Ann Surg Oncol; 2008 Sep; 15(9):2426-32. PubMed ID: 18521686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis arising from appendix: preliminary results of a survival analysis.
    Marcotte E; Sideris L; Drolet P; Mitchell A; Frenette S; Leblanc G; Leclerc YE; Dubé P
    Ann Surg Oncol; 2008 Oct; 15(10):2701-8. PubMed ID: 18654822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 120 peritoneal carcinomatoses from colorectal cancer treated with peritonectomy and intra-abdominal chemohyperthermia: a S.I.T.I.L.O. multicentric study.
    Cavaliere F; Valle M; De Simone M; Deraco M; Rossi CR; Di Filippo F; Verzi S; Giannarelli D; Perri P; Pilati PL; Vaira M; Di Filippo S; Garofalo A
    In Vivo; 2006; 20(6A):747-50. PubMed ID: 17203760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma: non-mucinous tumour associated with an improved survival.
    Yan TD; Chu F; Links M; Kam PC; Glenn D; Morris DL
    Eur J Surg Oncol; 2006 Dec; 32(10):1119-24. PubMed ID: 16887321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of peritoneal carcinomatosis from colorectal cancer by cytoreductive surgery and hyperthermic perioperative intraperitoneal chemotherapy.
    Kecmanovic DM; Pavlov MJ; Ceranic MS; Sepetkovski AV; Kovacevic PA; Stamenkovic AB
    Eur J Surg Oncol; 2005 Mar; 31(2):147-52. PubMed ID: 15698730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of hyperthermic intraperitoneal chemoperfusion with high-dose oxaliplatin in patients with peritoneal carcinomatosis.
    Ceelen WP; Peeters M; Houtmeyers P; Breusegem C; De Somer F; Pattyn P
    Ann Surg Oncol; 2008 Feb; 15(2):535-41. PubMed ID: 17960463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Elias D; Honoré C; Ciuchendéa R; Billard V; Raynard B; Lo Dico R; Dromain C; Duvillard P; Goéré D
    Br J Surg; 2008 Sep; 95(9):1164-71. PubMed ID: 18690633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: location, treatment, and outcome.
    Verwaal VJ; Boot H; Aleman BM; van Tinteren H; Zoetmulder FA
    Ann Surg Oncol; 2004 Apr; 11(4):375-9. PubMed ID: 15070596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center experience.
    Scaringi S; Kianmanesh R; Sabate JM; Facchiano E; Jouet P; Coffin B; Parmentier G; Hay JM; Flamant Y; Msika S
    Eur J Surg Oncol; 2008 Nov; 34(11):1246-52. PubMed ID: 18222622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.
    Verwaal VJ; van Ruth S; de Bree E; van Sloothen GW; van Tinteren H; Boot H; Zoetmulder FA
    J Clin Oncol; 2003 Oct; 21(20):3737-43. PubMed ID: 14551293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal colorectal carcinomatosis: a newly validated standard whose contribution remains to be assessed].
    Pocard M; Boige V
    Bull Cancer; 2005 Feb; 92(2):151-4. PubMed ID: 15749644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.
    Glehen O; Kwiatkowski F; Sugarbaker PH; Elias D; Levine EA; De Simone M; Barone R; Yonemura Y; Cavaliere F; Quenet F; Gutman M; Tentes AA; Lorimier G; Bernard JL; Bereder JM; Porcheron J; Gomez-Portilla A; Shen P; Deraco M; Rat P
    J Clin Oncol; 2004 Aug; 22(16):3284-92. PubMed ID: 15310771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center.
    Gusani NJ; Cho SW; Colovos C; Seo S; Franko J; Richard SD; Edwards RP; Brown CK; Holtzman MP; Zeh HJ; Bartlett DL
    Ann Surg Oncol; 2008 Mar; 15(3):754-63. PubMed ID: 18080166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Nonaka D; Oliva GD; Laterza B; Deraco M
    Ann Surg Oncol; 2007 Oct; 14(10):2790-7. PubMed ID: 17661150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer.
    da Silva RG; Sugarbaker PH
    J Am Coll Surg; 2006 Dec; 203(6):878-86. PubMed ID: 17116556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms.
    Yan TD; Bijelic L; Sugarbaker PH
    Ann Surg Oncol; 2007 Aug; 14(8):2289-99. PubMed ID: 17541772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of systematic second-look surgery in patients at high risk of developing colorectal peritoneal carcinomatosis.
    Elias D; Goéré D; Di Pietrantonio D; Boige V; Malka D; Kohneh-Shahri N; Dromain C; Ducreux M
    Ann Surg; 2008 Mar; 247(3):445-50. PubMed ID: 18376188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.
    Bijelic L; Yan TD; Sugarbaker PH
    Ann Surg Oncol; 2007 Aug; 14(8):2281-8. PubMed ID: 17503156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I trial of pegylated liposomal doxorubicin with hyperthermic intraperitoneal chemotherapy in patients undergoing cytoreduction for advanced intra-abdominal malignancy.
    Harrison LE; Bryan M; Pliner L; Saunders T
    Ann Surg Oncol; 2008 May; 15(5):1407-13. PubMed ID: 18157576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.